Daymark Wealth Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.84M Sell
31,616
-2,220
-7% -$478K 0.19% 99
2026
Q1
$6.79M Buy
33,836
+27,964
+476% +$5.78M 0.21% 91
2025
Q4
$1.21M Sell
5,872
-7
-0.1% -$1.4K 0.04% 259
2025
Q3
$1.05M Buy
5,879
+128
+2% +$21.8K 0.04% 275
2025
Q2
$928K Buy
5,751
+500
+10% +$79.6K 0.04% 272
2025
Q1
$893K Sell
5,251
-55
-1% -$9.55K 0.04% 257
2024
Q4
$882K Buy
5,306
+141
+3% +$24.1K 0.04% 254
2024
Q3
$888K Sell
5,165
-98
-2% -$16.2K 0.04% 261
2024
Q2
$810K Buy
5,263
+25
+0.5% +$3.75K 0.04% 266
2024
Q1
$805K Sell
5,238
-201
-4% -$30.6K 0.04% 218
2023
Q4
$860K Hold
5,439
0.05% 197
2023
Q3
$796K Sell
5,439
-1,003
-16% -$153K 0.05% 191
2023
Q2
$987K Sell
6,442
-333
-5% -$51.9K 0.07% 169
2023
Q1
$1.05M Sell
6,775
-30
-0.4% -$4.71K 0.14% 122
2022
Q4
$1.05M Buy
+6,805
New +$1M 0.19% 90

Other funds holding FBT

Daymark Wealth Partners's FBT Position: Q2 2026 in Review

Daymark Wealth Partners reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 6.6% in Q2 2026, selling an estimated $478K and leaving 31,616 shares worth $7.84M. The position accounts for 0.19% of the portfolio, ranked #99.

Daymark Wealth Partners first reported a position in FBT in Q4 2022 and has held it in 15 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Daymark Wealth Partners held 31,616 shares of First Trust NYSE Arca Biotechnology Index Fund worth $7.84M as of Q2 2026.
  • Daymark Wealth Partners sold 2,220 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $478K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.19% of Daymark Wealth Partners's portfolio in Q2 2026, its #99 holding.
  • Daymark Wealth Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2022 and has held it in 15 quarters since.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Daymark Wealth Partners's 13F filing for Q2 2026, filed 31 Jul 2026.